Blue cone monochromacy is a rare X-linked retina disorder. It causes a complete or near-complete loss of function in the L- and M-cones responsible for color vision.

Deletion of the locus-control region is known to cause S-cone monochromacy, in which neither the L- and M cones are functional. 20, 21 Therefore, the 40% activity in the M gene promoter with − ...

Adverum Biotechnologies Granted Orphan Drug Designation by FDA for Gene Therapy Candidate in Preclinical Development for the Treatment of Blue Cone Monochromacy Published Jan 4, 2022 8:00am EST ...

ADVM-062, a novel gene therapy candidate, received orphan drug designation from the FDA for the treatment of blue cone monochromacy, according to a press release from Adverum Biotechnologies.The ...

(HealthDay)—Imagine a world in black and white. That's the plight of people with an extremely rare condition called blue cone monochromacy, an inherited eye disease that renders people unable to ...

Blue Cone Monochromacy, a rare form of colorblindness, affects 1 in 100,000 individuals. It leads to poor or no color discrimination, which is why the photo above looks sort of like it’s been ...

- ADVM-062 is designed as a potential treatment for blue cone monochromacy (X-linked incomplete achromatopsia) -REDWOOD CITY, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc ...

(2016-01-06) AGTC and BCM Families Foundation Announce Collaboration to Develop AAV-Based Gene Therapy for Blue Cone Monochromacy Stockhouse.com uses cookies on this site. By continuing to use our ...